Facing colorectal cancer surgery with extra pounds? A new study reveals that shedding weight beforehand could be a game-changer for safety and recovery—let's dive into the details!
For those preparing for surgery to remove colorectal cancer, losing weight in advance might seem like an obvious step, but it's not always straightforward. A recent UK-based study published in JAMA Network Open shows that a carefully planned program using a low-energy total diet replacement can help patients achieve this safely, boost their post-surgery quality of life, and even prove cost-effective. But here's where it gets controversial—while this approach brought benefits, past research warns of hidden pitfalls. Stick around to explore how it all unfolds.
The study, known as CARE, was a randomized clinical trial conducted across eight hospitals in England from March 2023 to August 2024. It focused on adults with a body mass index (BMI) of 28 or higher—think of BMI as a simple measure that compares your height and weight to estimate if you're in a healthy range, with 28+ indicating excess weight—who were slated for elective surgery to cure colorectal cancer. These patients were split into two groups: one receiving standard care, like typical pre-surgery advice, and the other following an intensive weight loss plan. The intervention involved a low-energy total diet replacement, which means replacing regular meals with specially formulated shakes or meals providing just 800 calories per day while packing in 76 grams of protein to keep muscles strong. Dietitians offered support through phone calls, making it accessible and guided.
Now, for beginners wondering why this matters, weight loss before surgery isn't just about fitting into smaller scrubs. Excess weight can complicate operations by increasing risks like infections or longer recovery times, while unintended weight loss from illness can lead to malnutrition, slowing healing. Previous studies have shown that losing more than 3% of your body weight unintentionally in the six months before surgery can delay recovery and boost readmission chances. This new research flips the script by demonstrating that intentional, monitored weight loss might sidestep those issues.
And this is the part most people miss—the study wasn't just about dropping pounds; it tracked feasibility, safety, and real-world impacts. Out of 150 people approached, 71 joined (36 in the intervention, 35 in standard care), with an average age of 64 and a high average BMI of 35.4. Participants in the weight loss group stuck to 85% of their dietitian calls and hit a 5% or more weight loss goal 61% of the time, compared to just 9% in the standard care group. On average, they shed 6.1 kilograms (about 13.4 pounds), which was 4.3 kilograms more than the other group, without losing muscle mass—fat-free mass stayed steady, changing by just 0.1 kilograms. That's crucial because muscle helps with recovery and everyday function; losing it could weaken you post-surgery.
The results extended beyond the scale. While overall post-surgery complications were similar between groups (around 39-40%), specific symptoms improved dramatically in the weight loss group. Fecal incontinence—think of it as difficulty controlling bowel movements—dropped by 8.6 points on a symptom scale, and sore skin issues decreased by 15.9 points. An exploratory look even suggested that losing at least 3.2% of body weight cut complications by half. Plus, early cost-effectiveness modeling over 30 years hinted that the program could save money in the long run by reducing healthcare needs, making it a smart investment for broader use.
But let's talk controversy—while the study paints a positive picture, it's not without its critics. The researchers noted that the standard care group still lost about 2 kilograms, possibly because being in a trial motivated them. Participants were generally healthier than the broader population, and the weekly dietitian check-ins might have made minor side effects more noticeable. Future research needs to include more vulnerable patients and use finer measures, like the Comprehensive Complication Index, to catch subtler issues. Critics might argue this intensive diet could be too restrictive or risky for those already frail, echoing older findings on unintentional weight loss.
Despite these caveats, the team believes this method is feasible, safe, and well-tolerated, with no serious side effects and clear perks for symptoms. As they put it, it's a promising prehabilitation tool for colorectal cancer surgery.
What do you think? Should this weight loss program become standard before colorectal cancer operations, or could it backfire for some patients? Share your thoughts in the comments—do you agree with the findings, or see potential downsides?
Stay informed on the latest in healthcare policy, costs, and value—subscribe to AJMC for expert insights blending clinical care with economic realities.
